Literature DB >> 4018909

Tumor-derived chemotactic factor(s) from human ovarian carcinoma: evidence for a role in the regulation of macrophage content of neoplastic tissues.

B Bottazzi, P Ghezzi, G Taraboletti, M Salmona, N Colombo, C Bonazzi, C Mangioni, A Mantovani.   

Abstract

Supernatants from freshly disaggregated human ovarian carcinomas maintained in vitro for 24 hr, from primary ovarian carcinoma cultures (4-6 days in culture) and from established ovarian cancer cell lines were examined for chemotactic activity on blood monocytes in blind-well chemotaxis chambers. Tumor-cell culture supernatants induced migration of peripheral blood monocytes across polycarbonate filters with considerable heterogeneity among different tumors. Induction of migration occurred only in the presence of a gradient between the lower and upper compartments of the chamber. Chemotactic activity was characterized by means of supernatants from primary ovarian carcinoma cultures. Chemotactic factor(s) was (were) produced in serum-free conditions and the production was inhibited by emetine but not by mitomycin C. The activity was destroyed by exposure to proteolytic enzymes and by heating at 100 degrees C but was unaffected by RNase, DNase, lipase and exposure to extreme pH values or heating at 56 degrees C. Upon fractionation on Sephadex G 75, the activity eluted as a single peak in the cytochrome C region, corresponding to an apparent molecular weight of about 12 kd. The percentage of macrophages was assessed in 25 freshly disaggregated tumor specimens. Ovarian carcinomas were heterogeneous in their macrophage content with values ranging from 4 to 36%. A significant (r = 0.62; p = 0.00097), though far from absolute, correlation was found between chemotactic activity of culture supernatants and percentage of tumor-associated macrophages. Tumor-derived chemotactic factor(s) could be one of the mechanisms involved in the regulation of the macrophage content of human ovarian carcinomas.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4018909     DOI: 10.1002/ijc.2910360207

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

1.  Liposome-encapsulated muramyl tripeptide up-regulates monocyte chemotactic and activating factor gene expression in human monocytes at the transcriptional and post-transcriptional levels.

Authors:  T Asano; K Matsushima; E S Kleinerman
Journal:  Cancer Immunol Immunother       Date:  1994-01       Impact factor: 6.968

2.  Expression of monocyte chemoattractant protein 1 in human inflamed gingival tissues.

Authors:  X Yu; H N Antoniades; D T Graves
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

3.  The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer.

Authors:  R P Negus; G W Stamp; M G Relf; F Burke; S T Malik; S Bernasconi; P Allavena; S Sozzani; A Mantovani; F R Balkwill
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

4.  Expression of the JE/MCP-1 gene suppresses metastatic potential in murine colon carcinoma cells.

Authors:  S Huang; R K Singh; K Xie; M Gutman; K K Berry; C D Bucana; I J Fidler; M Bar-Eli
Journal:  Cancer Immunol Immunother       Date:  1994-10       Impact factor: 6.968

5.  Epithelial ovarian cancer: a cytokine propelled disease?

Authors:  S Malik; F Balkwill
Journal:  Br J Cancer       Date:  1991-10       Impact factor: 7.640

6.  Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants.

Authors:  T Yoshimura; E A Robinson; S Tanaka; E Appella; J Kuratsu; E J Leonard
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

7.  Analysis of CC chemokine and chemokine receptor expression in solid ovarian tumours.

Authors:  C Scotton; D Milliken; J Wilson; S Raju; F Balkwill
Journal:  Br J Cancer       Date:  2001-09-14       Impact factor: 7.640

8.  Tumour cell derived effects on monocyte/macrophage polarization and function and modulatory potential of Viscum album lipophilic extract in vitro.

Authors:  Myriam Estko; Stephan Baumgartner; Konrad Urech; Matthias Kunz; Ursula Regueiro; Peter Heusser; Ulrike Weissenstein
Journal:  BMC Complement Altern Med       Date:  2015-04-24       Impact factor: 3.659

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.